Antibodies Drugs have emerged as vital therapeutics in the pharmaceutical industry, offering targeted treatment solutions for a variety of chronic and complex diseases. These drugs are instrumental in modulating immune responses, managing autoimmune disorders, and enhancing precision medicine approaches. The global current value of Antibodies Drugs was valued at USD 4.30 billion in 2024, with a...

Cancer remains one of the most critical global health challenges, increasing dependence on effective drug-based therapies. The global value of anti-cancer drugs was estimated at around USD 185 billion in 2024 and is expected to exceed USD 320 billion by 2032, growing at a compound annual growth rate (CAGR) of approximately 7.2%. Rising cancer incidence, expanding treatment access, and...